This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Yishai Avior: Innovator in Stem Cell Research
Introduction
Yishai Avior is a prominent inventor based in Rosh-Ha′ayin, Israel. He has made significant contributions to the field of stem cell research, particularly in the area of hepatocyte maturation. His innovative work has the potential to impact various medical applications.
Latest Patents
Yishai Avior holds a patent titled "Methods of inducing metabolic maturation of human pluripotent stem cells—derived hepatocytes." This patent outlines methods for increasing the metabolic maturation of immature hepatocytes. The process involves contacting immature hepatocytes that express alpha-fetoprotein (AFP) and albumin with an effective amount of specific fatty acids or small molecules. These include compounds such as Thiazolidinedione (TZD), GW409544, and Gemfibrozil, among others. The patent also provides insights into isolated hepatocytes and their potential uses.
Career Highlights
Yishai Avior is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this institution has allowed him to explore innovative solutions in stem cell technology. He has demonstrated a commitment to advancing scientific knowledge and practical applications in the field.
Collaborations
Yishai Avior has collaborated with notable colleagues, including Michal Zimerman and Gahl Levy. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Yishai Avior's contributions to stem cell research exemplify the importance of innovation in medical science. His patent on hepatocyte maturation represents a significant advancement in the field, showcasing his dedication to improving healthcare solutions.